Cutting-edge artificial intelligence platform to analyze antipsychotic drug use data from leading brain development institute to predict patient outcomes. WASHINGTON DC, and BALTIMORE, MD – Feb. 15th, 2018 ― BullFrog…
Continue Reading
For media inquiries, please contact:
Recent Articles
- BullFrog AI and TTi Health Research & Economics Announce Partnership
- BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development
- BullFrog AI Secures $200K from TEDCO’s Seed Fund
- BullFrog AI Signs Memorandum of Understanding with KBP Biosciences
- BullFrog AI Announces New Chief Technology Officer